Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 31;16(11):2105.
doi: 10.3390/cancers16112105.

MRI for Differentiation between HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma: A Systematic Review

Affiliations
Review

MRI for Differentiation between HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma: A Systematic Review

Linda L Chen et al. Cancers (Basel). .

Abstract

Human papillomavirus (HPV) is an important risk factor for oropharyngeal squamous cell carcinoma (OPSCC). HPV-positive (HPV+) cases are associated with a different pathophysiology, microstructure, and prognosis compared to HPV-negative (HPV-) cases. This review aimed to investigate the potential of magnetic resonance imaging (MRI) to discriminate between HPV+ and HPV- tumours and predict HPV status in OPSCC patients. A systematic literature search was performed on 15 December 2022 on EMBASE, MEDLINE ALL, Web of Science, and Cochrane according to PRISMA guidelines. Twenty-eight studies (n = 2634 patients) were included. Five, nineteen, and seven studies investigated structural MRI (e.g., T1, T2-weighted), diffusion-weighted MRI, and other sequences, respectively. Three out of four studies found that HPV+ tumours were significantly smaller in size, and their lymph node metastases were more cystic in structure than HPV- ones. Eleven out of thirteen studies found that the mean apparent diffusion coefficient was significantly higher in HPV- than HPV+ primary tumours. Other sequences need further investigation. Fourteen studies used MRI to predict HPV status using clinical, radiological, and radiomics features. The reported areas under the curve (AUC) values ranged between 0.697 and 0.944. MRI can potentially be used to find differences between HPV+ and HPV- OPSCC patients and predict HPV status with reasonable accuracy. Larger studies with external model validation using independent datasets are needed before clinical implementation.

Keywords: apparent diffusion coefficient; head and neck carcinoma; human papillomavirus; magnetic resonance imaging; oropharyngeal squamous cell carcinoma; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1
Figure 1
Flowchart of study selection, consistent with preferred reporting items for systematic reviews (PRISMA) statement [33].
Figure 2
Figure 2
Overview of QUADAS-2 results. RoB = risk of bias; Appl = applicability.
Figure 3
Figure 3
Mean apparent diffusion coefficient (ADCmean) of HPV+ and HPV− lesions with decreasing ADC for HPV− from left to right. If median was reported instead of mean, we used the median. Asterisks (*) denote a significant difference between HPV+ and HPV− groups [2,25,27,28,29,38,39,41,42,44,45,46,49]. A significant difference between HPV+ and HPV− lesions was found in all studies (left of the dashed line), except for Schouten et al. and Han et al. [28,49].

Similar articles

References

    1. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., Zahurak M.L., Daniel R.W., Viglione M., Symer D.E., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 2000;92:709–720. doi: 10.1093/jnci/92.9.709. - DOI - PubMed
    1. De Perrot T., Lenoir V., Ayllón M.D., Dulguerov N., Pusztaszeri M., Becker M. Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology. AJNR Am. J. Neuroradiol. 2017;38:2153–2160. doi: 10.3174/ajnr.A5370. - DOI - PMC - PubMed
    1. Ang K.K., Harris J., Wheeler R., Weber R., Rosenthal D.I., Nguyen-Tân P.F., Westra W.H., Chung C.H., Jordan R.C., Lu C., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 2010;363:24–35. doi: 10.1056/NEJMoa0912217. - DOI - PMC - PubMed
    1. Lewis J.S., Mirabello L., Liu P., Wang X., Dupont W.D., Plummer W.D., Pinheiro M., Yeager M., Boland J.F., Cullen M., et al. Oropharyngeal Squamous Cell Carcinoma Morphology and Subtypes by Human Papillomavirus Type and by 16 Lineages and Sublineages. Head Neck Pathol. 2021;15:1089–1098. doi: 10.1007/s12105-021-01318-4. - DOI - PMC - PubMed
    1. Marur S., Burtness B. Oropharyngeal squamous cell carcinoma treatment: Current standards and future directions. Curr. Opin. Oncol. 2014;26:252–258. doi: 10.1097/CCO.0000000000000072. - DOI - PMC - PubMed

LinkOut - more resources